Insulet (PODD) EBT (2010 - 2026)

Insulet has reported EBT for 17 years, with the latest figure at $113.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBT rose 134.44% year-over-year to $113.0 million; the trailing twelve-month figure through Mar 2026 stood at $404.4 million (up 37.74% YoY), and the FY2025 full-year result was $339.5 million, up 13.09% from the prior year.
• EBT for Q1 2026 stood at $113.0 million, down from $140.2 million in the prior quarter.
• The five-year high for EBT was $140.2 million in Q4 2025, with the low at -$36.1 million in Q2 2022.
• Historically, EBT has averaged $57.5 million across 5 years, with a median of $51.1 million in 2024.
• The largest YoY upside for EBT was 9666.67% in 2022 against a maximum downside of 137.5% in 2022.
• Insulet's EBT stood at $22.3 million in 2022, then surged by 383.86% to $107.9 million in 2023, then grew by 3.24% to $111.4 million in 2024, then grew by 25.85% to $140.2 million in 2025, then fell by 19.4% to $113.0 million in 2026.
• The last three EBT figures came in at $113.0 million (Q1 2026), $140.2 million (Q4 2025), and $122.8 million (Q3 2025), per Business Quant data.